User:Timeshifter/Sandbox229

See: Template talk:Sticky header#Borders on sticky headers in Firefox tables

Multi-row header

Without sticky template

rowspan and colspan

Name	Data columns are below
	1	2	3
Name1	1-1	2-1	3-1
Name2	1-2	2-2	3-2
Name3	1-3	2-3	3-3
Name4	1-4	2-4	3-4
Name5	1-5	2-5	3-5
Name6	1-6	2-6	3-6

With sticky template

rowspan and colspan

Name	Data columns are below
	1	2	3
Name1	1-1	2-1	3-1
Name2	1-2	2-2	3-2
Name3	1-3	2-3	3-3
Name4	1-4	2-4	3-4
Name5	1-5	2-5	3-5
Name6	1-6	2-6	3-6

Wiki source excerpt:

{{mw-datatable}}{{sort under}}
{| class="wikitable sortable mw-datatable sort-under sticky-header" 
|+ rowspan and colspan
|-
! rowspan=2 | Name
! colspan=3 style=max-width:8em | Data columns are below
|- 
! 1
! 2
! 3
|-
...

Wiki source. Full table:

{{mw-datatable}}{{sort under}}
{| class="wikitable sortable mw-datatable sort-under sticky-header" 
|+ rowspan and colspan
|-
! rowspan=2 | Name
! colspan=3 style=max-width:8em | Data columns are below
|- 
! 1
! 2
! 3
|-
| Name1 || 1-1 || 2-1 || 3-1
|-
| Name2 || 1-2 || 2-2 || 3-2
|-
| Name3 || 1-3 || 2-3 || 3-3
|-
| Name4 || 1-4 || 2-4 || 3-4
|-
| Name5 || 1-5 || 2-5 || 3-5
|-
| Name6 || 1-6 || 2-6 || 3-6
|}

Single-row header

COVID-19 vaccines authorized for emergency use or approved for full use

Common name	Type (technology)	Country of origin	First authorization	Notes
Authorized in more than 10 countries
Oxford–AstraZeneca	Adenovirus vector	United Kingdom, Sweden	December 2020
Pfizer–BioNTech	RNA	Germany, United States	December 2020	Both original and Omicron variant versions
Janssen (Johnson & Johnson)	Adenovirus vector	United States, Netherlands	February 2021
Moderna	RNA	United States	December 2020	Both original and Omicron variant versions
Sinopharm BIBP	Inactivated	China	July 2020
Sputnik V	Adenovirus vector	Russia	August 2020
CoronaVac	Inactivated	China	August 2020	Low efficacy in replication studies and with certain variants
Novavax	Subunit/virus-like particle	United States	December 2021	A "recombinant nanoparticle vaccine"
Covaxin	Inactivated	India	January 2021
Valneva	Inactivated	France, Austria	April 2022
Sanofi–GSK	Subunit	France, United Kingdom	November 2022	Based on Beta variant
Sputnik Light	Adenovirus vector	Russia	May 2021
Authorized in 2–10 countries
Convidecia	Adenovirus vector	China	June 2020
Sinopharm WIBP	Inactivated	China	February 2021	Lower efficacy
Abdala	Subunit	Cuba	July 2021
EpiVacCorona	Subunit	Russia	October 2020
Zifivax	Subunit	China	March 2021
Soberana 02	Subunit	Cuba, Iran	June 2021
CoviVac	Inactivated	Russia	February 2021
Medigen	Subunit	Taiwan	July 2021
QazCovid-in	Inactivated	Kazakhstan	April 2021
Minhai	Inactivated	China	May 2021	Undergoing clinical trials
COVIran Barekat	Inactivated	Iran	June 2021
Soberana Plus	Subunit	Cuba	August 2021
Corbevax	Subunit	India, United States	December 2021
Authorized in 1 country
Chinese Academy of Medical Sciences	Inactivated	China	June 2021
ZyCoV-D	DNA	India	August 2021
FAKHRAVAC	Inactivated	Iran	September 2021
COVAX-19	Subunit	Australia, Iran	October 2021
Razi Cov Pars	Subunit	Iran	October 2021
Turkovac	Inactivated	Turkey	December 2021
Sinopharm CNBG	Subunit	China	December 2021	Based on original, Beta, and Kappa variants
CoVLP	Virus-like particle	Canada, United Kingdom	February 2022
Noora	Subunit	Iran	March 2022
Skycovione	Subunit	South Korea	June 2022
Walvax	RNA	China	September 2022
iNCOVACC	Adenovirus vector	India	September 2022	Nasal vaccine
V-01	Subunit	China	September 2022
Gemcovac	RNA	India	October 2022	Self-amplifying RNA vaccine
IndoVac	Subunit	Indonesia	October 2022